Elias Jabbour, MD
The University of Texas MD Anderson Cancer Center
Latest Content
CML and Ph+ ALL
11/05/2026
Ep. 2: OPTIC Study Informs Ponatinib Dosing and Treatment Sequencing in CML
CML and Ph+ ALL
10/29/2026
The University of Texas MD Anderson Cancer Center
CML and Ph+ ALL
11/05/2026
CML and Ph+ ALL
10/29/2026